Background/Aims: Zinc finger protein 703 (ZNF703), initially identified as a novel oncogene in human breast cancer, is a member of the NET/NlZ family of zinc finger transcription factors. It is recognized that the overexpression of ZNF703 is associated with various types of human cancers, but the role and molecular mechanism of ZNF703 in oral squamous cell carcinoma (OSCC) are unknown. Methods: ZNF703 expression levels were examined in OSCC tissues and non-cancerous tissues by qRT-PCR and immunohistochemistry (IHC). The molecular mechanisms of ZNF703 and its effects on cell growth and metastasis were explored in vitro and in vivo using the CCK8 assay, colony formation assay, cell cycle analysis, migration and invasion assays, wound-healing assay, western blotting and xenograft experiments in nude mice. Results: In this study, ZNF703 was found to be upregulated in OSCC tissues compared to that in normal tissues at both mRNA and protein levels, and its expression level was closely correlated with the overall survival of patients with OSCC. Silencing of the ZNF703 gene in OSCC cells significantly inhibited cell growth and metastasis in vitro and in vivo. Conversely, the overexpression of ZNF703 in OSCC cells promoted cancer growth and metastasis in vitro. Mechanistically, ZNF703 activated the PI3K/AKT/GSK-3β signalling pathway and its downstream effectors, thus regulating the cell cycle and epithelial-mesenchymal transition (EMT). Furthermore, the promotive effects of ZNF703 on cellular proliferation and metastasis could be rescued by LY294002 (a PI3K-specific inhibitor) and MK2206 (an Akt-specific inhibitor). Conclusion: The results show that ZNF703 promotes cell growth and metastasis
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Introduction
Oral cancer is a malignancy of the lip or oral cavity. It is one of the 10 most common cancers in the world, and 90% of oral cancer cases are oral squamous cell carcinoma (OSCC) [1] . Surgery, radiation therapy and coadjutant therapy are common approaches used in the treatment of OSCC [2] . Despite advances in surgery and radiotherapy, which remain the standard treatment options, the prognosis of patients with OSCC is still poor, and the mortality rate has remained largely unchanged for decades [3] . Unfortunately, most of the OSCC cases are diagnosed at advanced stages (III or IV), with the 5-year overall survival rate varying between 40% and 50% and a cure rate of 30% [4] [5] [6] . Therefore, early diagnosis and treatment remain the key elements for improving the survival of patients.
Zinc finger protein 703 (ZNF703), encoded by a gene in chromosome 8p11-12, is a member of the NET family of zinc finger transcription factors [7, 8] . Members of the NET (for NocA, Nlz, Elbow, and TLP-1) family have recently been shown to play important roles in embryonic development and tumour progression [9, 10] . It has been shown that ZNF703 is overexpressed in several types of malignancies, including breast cancer [11] , lung cancer [12] , gastric cancer [13] , colorectal cancer [14] and cholangiocarcinoma [15] , and its high expression promotes the progression of these cancers. Investigations have confirmed that ZNF703 can complex with Groucho and repress E-cadherin, Wnt and TGF-β reporter expression to regulate cell adhesion, migration, and proliferation in breast cancer [16] . Overexpressed ZNF703 was shown to increase lung metastases in a mouse model of breast cancer and to be an independent unfavourable prognostic factor for the survival of patients with luminal B breast cancer [11, 17] . In addition, overexpressed ZNF703 was shown to contribute to tumour progression in non-small cell lung cancer by activating the Akt/mTOR signalling pathway [12] . However, the role and molecular mechanism of ZNF703 in OSCC are still unclear.
Thus, this study was designed to explore the role of ZNF703 in the development and progression of OSCC. In this study, we determined that ZNF703 was upregulated in OSCC and that its overexpression increased the oncogenic potential, especially proliferation, migration and invasion, of OSCC by activating the PI3K/Akt/GSK-3β signalling pathway and its downstream effectors.
Materials and Methods

Cell culture, Sample collection, and Ethics Statement
The OSCC cell lines Tca-8113 and KB were maintained in RPMI-1640 medium supplemented with 10% foetal bovine serum (FBS) (PAA Laboratories, Inc, Pasching, Austria). The cells were incubated in a humidified chamber with 5% CO2 at 37°C. Twenty-five freshly isolated OSCC tissues, 15 freshly isolated non-cancerous tissues, 95 paraffin-embedded OSCC tissues and 24 paraffin-embedded non-cancerous specimens were obtained at the time of diagnosis before any therapy from the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou. Among the 95 OSCC patients, there were 55 males and 40 females with ages ranging from 17 to 79 years (median, 48.18 years). All clinical protocols were approved by the Ethics Committees of the Third Affiliated Hospital of Guangzhou Medical University, and informed consent was obtained from the patients.
Immunohistochemistry
Immunohistochemistry and evaluation of ZNF703 staining (1:100, GTX107721, GeneTex) were performed in OSCC and non-cancerous oral tissues according to previously described methods [18] .
RNA Isolation, Reverse Transcription, and qRT-PCR
RNA was extracted from the OSCC cell lines, 22 fresh OSCC tissues and 12 fresh non-cancerous oral tissues using TRIzol (Takara, Shiga, Japan). For the evaluation of ZNF703 expression, RNA was transcribed into cDNA and amplified with the specific sense primer: 5'-GATCAGGGTCCTGAAGATGC-3' and antisense primer: 5'-CCGAGTTGAGTTTGGAGGAG-3'. The assays were performed in accordance with the manufacturer's instructions (Takara). PCR amplification was repeated three times for each gene, and ARF5 was used as an internal control.
Western Blot Analysis
Cells were lysed in RIPA buffer (Beyotime, China), and protein concentration was determined using the BCA kit (Beyotime, China). Total protein (25 μg) was resolved using a 10% SDS-polyacrylamide gel electrophoresis (PAGE) gel and electro-transferred onto polyvinylidene fluoride membranes (PVDF) (Millipore Corp, USA). The membranes were blocked with 5% non-fat dry milk (with BSA for phosphorylation-specific antibodies) in Tris-buffered saline (pH 7.5), followed by immunoblotting overnight at 4°C with anti-ZNF703 antibody (1:1000; GTX107721, GeneTex); anti-GSK-3β, anti-p-GSK-3β (Ser9), anti-p-Akt (Ser473), anti-Akt, anti-p-PI3K (Tyr458) and anti-PI3K antibodies (1:1000, Cell Signalling Technology); anti-MYC, anti-CDK4, anti-CCND1, anti-E2F1, and anti-β-actin antibodies (1:500, Santa Cruz Biotechnology); and anti-MMP9, anti-Snail, anti-Vimentin, anti-N-cadherin, and anti-E-cadherin antibodies (1:1000, Cell Signalling Technology, Danvers, USA). HRP-conjugated antirabbit or anti-mouse IgG antibody was used as the secondary antibodies (Bio-Rad, Hercules, CA). Signals were detected by enhanced chemiluminescence (ECL, GE Healthcare, Buckinghamshire, UK).
Immunofluorescence
Cells were cultured overnight and fixed with 3.5% paraformaldehyde at 4°C for 30 min. After fixation, the cells were permeabilized in 0.2% Triton X-100 for 30 min at room temperature. After the blocking solution was washed out, the cells were incubated with primary antibody for 2 h, followed by incubation with secondary antibodies (Invitrogen) for 1 h at room temperature. Coverslips were then mounted onto the slides with mounting solution containing 0.2 mg/ml DAPI and sealed with nail polish.
Establishment of stable OSCC Tca-8113 and KB cells infected with ZNF703 overexpression constructs or ZNF703-targeting shRNA constructs
Lentiviruses carrying human ZNF703-targeting short hairpin RNA (shRNA) were generated using the pLVTHM-GFP lentiviral RNAi expression system (sense: 5'-CGCGTCCCCGCTGTATGGACAGAGACTAGCTTCAA-GAGAGCTAGTCTCTGTCCATACAGCTTTTTGGAAAT-3' and antisense: 5'-CGATTTCCAAAAAGCTGTATGGACA-GAGACTAGCTCTCTTGAAGCTAGTCTCTGTCCATACAGCGGGGA-3'). ZNF703 cDNA was cloned into an AgeIdigested pGC-FU-GFP lentiviral vector. Tca-8113 and KB cells were infected with lentiviruses carrying pGC-FU-ZNF703-GFP vector or pLVTHM-shZNF703-GFP vector as described in previous studies. Flow cytometry was used to select polyclonal cells with GFP expression for subsequent experiments.
Transient transfection with the Akt Inhibitor MK2206 or the PI3K Inhibitor LY294002
The Akt inhibitor MK2206 and the PI3K inhibitor LY294002 were purchased from Sigma-Aldrich. Approximately 24 h before transfection, Tca-8113-ZNF703 and KB-ZNF703 cells were plated in 6-well plates at 35-55% confluence. The Akt inhibitor MK2206 or the PI3K inhibitor LY294002 was then transfected into cells at a working concentration of 5 µM or 50 nM, respectively, using Lipofectamine 2000 (Invitrogen Carlsbad, CA) according to the manufacturer's protocol. After 48-72 h, cells were collected for subsequent experiments.
CCK8 Assay
The CCK8 assay was used to assess in vitro cell proliferation. After transfection with pGC-FU-ZNF703 or shRNA-ZNF703, cells were seeded in 96-well plates at a density of 2, 000 cells/well and incubated for 1, 2, 3, 4, 5, 6, or 7 days. For inhibitor assays, cells were seeded in 96-well plates at a density of 2, 000 cells/well and incubated for 1, 2 or 3 days. Ten microliters of the CCK8 reagent (Beyotime, China) was added to each well and incubated for 1 h. At the end of incubation, the absorbance value (OD) of each well was measured at 450 nm. Experiments were performed three times. 
Colony formation assay
Cells were plated in 6-well culture plates at a density of 200 cells/well and incubated for 14 days in a humidified chamber with 5% CO2 at 37°C. At the end of incubation, the cells were washed with PBS and stained with Giemsa solution. The number of colonies containing ≥50 cells was counted under a microscope. The efficiency of colony formation was calculated using (number of colonies/number of cells inoculated)×100%.
Cell Cycle Analysis
Cells were seeded in 10-cm plates in RPMI-1640 containing 10% FBS and incubated for 48 h. A total of 5×10 6 cells were harvested, washed with cold PBS, and fixed with 70% ice-cold ethanol. After 48 h, the fixed cells were washed with cold PBS and incubated with PBS containing propidium iodide (PI, 10 µg/ml) and RNase A (0.5 mg/ml) for 20 min. The DNA content of labelled cells was determined using flow cytometry (BD Biosciences). Each experiment was performed three times.
Migration and Invasion Assays
Cell migration and invasion assays were performed according to our previous study [18] . For the cell migration assay, a total of 1×10 6 cells in medium without FBS were seeded on a fibronectin-coated polycarbonate membrane insert in a transwell apparatus (Corning, USA). After incubation for 12 h, the cells adhering to the lower surface were fixed with methanol, stained with Giemsa solution, and counted under a microscope in five pre-determined fields. The procedure for the cell invasion assay was similar to that of the cell migration assay, except that the transwell membranes were pre-coated with 24 mg/ml Matrigel (R&D Systems, USA) and incubation for 16 h.
Wound-healing assay
For the wound-healing assay, cells were seeded in 6-well plates and incubated for 24 h in a humidified chamber with 5% CO2 at 37°C. At the end of incubation, three scratch wounds were made across each well using a P-200 pipette tip. Fresh RPMI-1640 medium containing 5% FBS was added. The cells were continuously incubated and the wound closure was observed for 48 h. Photographs were captured at 0 and 48 h.
In vivo tumour growth assay
The experiment was carried out according to a previously described protocol [18] . Briefly, cells were seeded in 10-cm plates and incubated for 48 h. At the end of incubation, cells were harvested and resuspended with serum-free medium. A total of 2×10 6 cells were subcutaneously injected into the left and right dorsal regions of 12 nude mice. The mice were maintained in a barrier facility on HEPA-filtered racks and fed an autoclaved laboratory rodent diet. After 30 days, fluorescence signals from cells were evaluated with a whole-body GFP imaging system (LightTools, Encinitas, CA, USA). The mice were sacrificed. Tumour tissues were excised and weighed. The IPP 5.0 software (Media Cybernetics, Silver Spring, MD, USA) was used for the analysis of whole-body optical images, which were used to visualize tumour growth and tumour area in real time.
In vivo metastasis assay
The experiment was carried out according to a previously described protocol [18] . Briefly, 5×10
6 cells were harvested and injected into the spleen of nude mice. After two months, all mice were sacrificed, and individual organs were excised. Metastatic tissues were analysed by H&E staining. Whole-body optical images were visualized to monitor primary tumour growth and formation of metastatic lesions.
Statistical Analysis
All data were analysed for statistical significance using SPSS 18.0 software. One-way ANOVA was used to compare the differences among groups for all in vitro experiments. The Chi-square test was used to analyse the relationship between ZNF703 expression levels and clinicopathological characteristics of patients. Survival analysis was performed using the Kaplan-Meier method. Two-tailed Student's t-test was used for comparisons between two independent groups. A value of P˂0.05 was considered statistically significant.
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Results
Upregulated expression of ZNF703 protein is unfavourable for OSCC patient prognosis
We analysed ZNF703 mRNA expression in OSCC tissues and non-cancerous tissues by real-time quantitative RT-PCR (qRT-PCR) and found that ZNF703 expression level was significantly increased in OSCC tissues in comparison with the level in non-cancerous tissues ( Fig.1-A) . We also analysed the expression levels of ZNF703 protein in 95 archived paraffinembedded OSCC specimens and 24 non-cancerous specimens by immunohistochemistry. Similar to the mRNA expression pattern, ZNF703 protein expression was significantly increased in OSCC tissues in comparison with the expression in non-cancerous tissues ( Table 1 ). The ZNF703 protein was localized in the cytoplasm and nucleus but mostly in the nucleus (Fig. 1-B-C) . Further, we analysed the relationship between clinicopathologic characteristics and ZNF703 expression levels in individuals with OSCC ( Table 2 ). In the 95 OSCC cases, the upregulation of ZNF703 was related to tumour size (T classification) (T1-T2 versus T3-T4), lymph-node metastasis (N classification) (N0-N1 versus N2-N3), distant metastasis (M classification) (M0 versus M1), and clinical stage (I-II versus III-IV) but not to patient age, sex, smoking status, alcohol use, disease recurrence, and tumour differentiation. In addition, we examined the association between ZNF703 protein expression levels and patient survival using Kaplan-Meier analysis with the log-rank test. The results indicated that the level of ZNF703 protein was significantly correlated with overall survival, as patients with high ZNF703 expression had significantly shorter survival than patients with negative or low ZNF703 expression ( Fig. 1-D) .
ZNF703 promotes cell proliferation, migration and invasion in vitro and in vivo
To determine the functional significance of ZNF703 in cell proliferation, migration and invasion, we first performed loss-of-function experiments. We used lentiviruses encoding 2-A) . Growth curves determined by the CCK8 assay and colony formation assay showed that suppressing ZNF703 significantly inhibited the growth and proliferation of shZNF703-Tca-8113 and shZNF703-KB cells in comparison with the growth and proliferation of the corresponding shcon cells (Fig. 2-B-C) . Wound-healing assay and transwell migration and invasion assays showed that silencing ZNF703 markedly suppressed the migration and invasion of shZNF703-Tca-8113 and shZNF703-KB cells in comparison with the migration and invasion of the corresponding sh-con cells (Fig. 2-E-F) . In addition, we also observed that the depletion of ZNF703 blocked cell cycle transition from G1 to S phase in shZNF703-Tca-8113 and shZNF703-KB cells compared to that in the corresponding sh-con cells (Fig. 2-D) . ZNF703 silencing also altered the cytoskeletal organization and polarity of shZNF703-Tca-8113 and shZNF703-KB cells, which were shortened and weakened in comparison to those in the corresponding sh-con cells (Fig. 2-G) . To assess the effect of ZNF703 on the growth and metastasis of OSCC in vivo, we studied tumourigenesis in nude mice. The results showed that the average volume of tumours derived from shZNF703-Tca-8113 and shZNF703-KB cells was significantly smaller than that of tumours derived from the corresponding sh-con cells (Fig. 3-H) . Compared with the corresponding sh-con cells, shZNF703-Tca-8113 and shZNF703-KB cells formed fewer metastatic nodules in the livers of nude mice (Fig. 3-I) .
Next, we investigated whether the overexpression of ZNF703 has an opposite effect on cell proliferation, migration and invasion. We used lentiviruses carrying the ZNF703 gene to enhance the expression of ZNF703 in Tca-8113 and KB cells (Fig. 4-A) . Interestingly, we observed the opposite results. The overexpression of ZNF703 enhanced the growth and Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry proliferation of Tca-8113 and KB cells (Fig. 4-B-D) . Furthermore, ZNF703 overexpression promoted the migration and invasion of Tca-8113 and KB cells (Fig. 4-E-F) . Therefore, ZNF703 significantly promoted cellular growth, migration and invasion in vitro and in vivo, and it thus plays an important role in the tumourigenesis of OSCC.
ZNF703 regulates the expression of cell cycle-and EMT-associated factors in OSCC cells
Based on the fact that ZNF703 promoted proliferation, migration and invasion in OSCC cell lines, we examined the expression of cell cycle-and EMT-associated proteins in ZNF703-downregulated cells. We found that the loss of ZNF703 blocked the expression of CDK4, CCND1, E2F1, c-Myc, MMP9, Snail, Vimentin and N-cadherin (Fig. 5-A-B) . Moreover, we observed that the depletion of ZNF703 increased the expression of E-cadherin (Fig. 5-A-B) .
ZNF703 modulates cell cycle progression and EMT through the PI3K/Akt /GSK-3β
signalling pathway PI3K and AKT have been reported as upstream factors regulating cell cycle progression and EMT [19, 20] . We also examined the effect of ZNF703 on the PI3K/Akt signalling pathway and found that the loss of ZNF703 reduced the expression of phosphorylated PI3K (Tyr458), Akt (Ser473) and GSK-3 (Ser9), whereas the expression of PI3K, Akt and GSK-3β remained unchanged (Fig. 5-C) . On the other hand, the specific inhibitor of PI3K LY294002 
and sh-con cell-injected mice and excised tumours obtained 30 days after i m p l a n t ation. Repr e s e n t ative images of H&E-s t a i n e d sections of primary tumours are shown. Mean weight of tumours measured 30 days after injection. B. External wholebody fluorescence images of liver were obtained 2 months after injection of cells into mouse spleen. Representative images of H&E-stained sections of metastatic tumours are shown. 
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Cellular Physiology and Biochemistry the specific inhibitor of Akt MK2206 to suppress the expression of Akt and found that the expression of phosphorylated Akt (Ser473) and GSK-3β (Ser9) and the downstream cell cycle-and EMT-associated factors were reduced in ZNF703-upregulated cells (Fig. 6-A) .
In addition, we observed that treatment with LY294002 and MK2206 suppressed the proliferative, migratory and invasive potentials of ZNF703-overexpressing cells (Fig. 6-B-C) . Taken together, we provide compelling evidence that attenuated ZNF703 expression suppresses cell proliferation, migration and invasion by inactivating the PI3K/Akt/GSK-3β signalling pathway in OSCC cells.
Discussion
ZNF703, a nuclear protein, is an oncogenic transcription factor that regulates the expression of multiple genes involved in transcriptional regulation, stem cell modulation, and proliferation and invasion in cancer cells [10, 21, 22] . The overexpression of ZNF703 is thought to play an important role in various human cancers [12, 13, 15, 23] ; however, the role and molecular mechanism if ZNF703 are not well understood in OSCC. , and p-GSK-3β (Ser9), whereas the levels of total PI3K, Akt and GSK-3β remained unchanged. β-actin served as the internal control. In this study, we assessed the expression level of ZNF703 in OSCC tissues and noncancerous tissues by immunohistochemistry and qRT-PCR and found for the first time that ZNF703 expression was significantly increased in OSCC tissues compared with that in noncancerous tissues at both mRNA and protein levels. Importantly, IHC staining showed that in OSCC cells, the ZNF703 protein is mainly expressed in the nucleus and partly in the cytoplasm and membrane. Furthermore, we analysed the correlation between ZNF703 expression and the clinicopathological characteristics of 95 OSCC patients and found that elevated ZNF703 expression was positively associated with T classification, N classification, distant metastasis and clinical stages of OSCC in patients. Moreover, we also observed that the high expression of ZNF703 in OSCC was negatively correlated with overall patient survival. Patients with higher expression of the ZNF703 protein had a shorter overall survival. All these results indicate that overexpression of ZNF703 may be an independent unfavourable prognostic factor for OSCC patients, which is consistent with the findings of previous studies examining the role of ZNF703 in some tumours [11, 14] .
Subsequently, we demonstrated that ZNF703 plays an oncogenic role in OSCC, especially in tumour proliferation, migration and invasion. Notably, the stable silencing of ZNF703 expression in Tca-8113 and KB cells significantly inhibited cellular proliferation, migration and invasion in vitro and in vivo. In contrast, the stable overexpression of ZNF703 in Tca-8113 and KB cells markedly enhanced cellular proliferation, migration and invasion in vitro. Altogether, these results suggested that ZNF703 promoted cell growth and metastasis in OSCC. Although ZNF703 has been shown to play crucial roles in OSCC, the precise molecular mechanisms through which ZNF703 affects proliferation, migration and invasion in oral squamous cell carcinoma remain largely unknown. It is well known that a high proliferative activity of tumour cells is associated with increased cell cycle progression [24] [25] [26] . Here, we found that downregulating ZNF703 expression blocked cell growth by suppressing cell cycle progression and repressing the expression of cell cycle G1/S checkpoint factors, including CDK4, CCND1, c-Myc and E2F1. Epithelial-mesenchymal transition (EMT) is significantly associated with the aggressiveness and metastatic potential of cancers [27] [28] [29] . The hallmark of EMT is the loss of the epithelial marker E-cadherin [30] , gain of the mesenchymal marker N-cadherin [31] , and the upregulation of transcriptional repressors, such as Zeb1, Twist, Snail and Slug [32, 33] . In this study, ZNF703 overexpression promoted EMT by upregulating the expression of EMT-associated markers N-cadherin, vimentin, snail and Slug and by downregulating the expression of E-cadherin. Consistent with previous studies in which ZNF703 overexpression promoted tumour metastasis in breast cancer by repressing the expression of E-cadherin [16] , we reached similar conclusions in OSCC. In addition, ZNF703 downregulation reduced the expression of MMP9, a member of the matrix metalloproteinase (MMP) family that accelerates the aggressiveness of many tumours [34, 35] .
The PI3K/AKT/GSK-3β pathway is a classical signalling pathway in tumourigenesis [36, 37] , and its activation upregulates the expression of Snail and Slug, thereby promoting EMT [20, 38, 39] and inducing the transition from G1 to S phase [40, 41] . In this study , we found that the loss of ZNF703 expression decreased the expression of p-PI3K, p-Akt, and p-GSK-3β. These results are similar to the findings of the study by Baykara et al. in which ZNF703 was shown to contribute to tumour development in NSCLC by activating the Akt/ mTOR pathway [12] . To specifically determine the effects of PI3K and Akt on the ZNF703-mediated promotion of cell proliferation and metastasis, we father employed the Akt inhibitor MK2206 and the PI3K inhibitor LY294002 to inhibit the expression of Akt and PI3K, respectively, in ZNF703-upregulated cells. Finally, we found that the PI3K inhibitor LY294002 inhibited the expression of phosphorylated PI3K (Tyr458), Akt (Ser473), and GSK-3β (Ser9) and the downstream cell cycle-and EMT-associated factors and that the Aktspecific inhibitor MK2206 suppressed the expression of phosphorylated Akt (Ser473) and GSK-3β (Ser9) and the downstream cell cycle-and EMT-associated factors.
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